White House Pushes 12-Year Exclusivity For Biologics In Trade Talks

esilverman As the latest round of the Trans Pacific Partnership trade talks ended in Salt Lake City, the US Trade Representative has been circulating documents that show the ...

The most popular stories and special reports in FierceBiotech Research, FiercePharmaManufacturing, and the rest of our Life Sciences publications

Alok Saboo FierceBiotech News

FiercePharma news, curated by the crowd

Tracy Staton It's the time of year when the days are short and dark, bears are hibernating, fires are burning and people are exclaiming, "Where did the year go?" Alas, ...

U.S. access group aims to block Indian patent for Gilead’s hot hep C drug

Tracy Staton Gilead Sciences' new hepatitis C drug sofosbuvir won preliminary backing from European regulators on Friday, with marketing approval expected to follow soon. The FDA ...

If Drug Prices Were Lower, Maine Would Not Need A Law: Wellman Explains

esilverman Earlier this year, Maine passed a law that allows its citizens to purchase prescription medications from a Canadian broker that deals with licensed retail pharmacies in ...

J&J, Medivir gain FDA OK for new hep C therapy simeprevir

John Carroll Johnson & Johnson and its partner Medivir won a green light from the FDA late on Friday to begin marketing their hepatitis C drug simeprevir, which will now be sold ...

New reports put India’s Torrent at forefront of buyers for Elder Pharmaceuticals

Eric Palmer The Economic Times now says Elder is deep into discussions with Indian drugmaker Torrent Pharma, which is talking about 1,700 crore ($ 291 million) for its peer. FiercePharma ...

Sanofi and Regeneron Report Positive Results with Sarilumab

mia.burns Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial Sarilumab, Given Subcutaneously Every Other ...

Fidelity, J&J back $27.5M round for U.K. respiratory startup

Damian Garde The U.K.'s Pulmocide has pulled down a $ 27.5 million Series A from a big-name cast of investors, setting out to discover and develop some inhaled drugs for viral ...

FDA approves GSK bird flu vaccine for U.S. stockpile

Eric Palmer The FDA has approved its first adjuvanted vaccine against a potential outbreak of the deadly bird flu. It just won't be available at the local pharmacy. FiercePharma ...

CHMP Issues Opinions

mia.burns Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 November 2013 This page provides an overview of the opinions adopted at the November ...

AB Science plummets as EU frowns on cancer drug

Damian Garde France's AB Science watched its shares tank as much as 31% on Friday after a European Medicines Agency panel rejected its gastrointestinal cancer treatment, casting ...
Page 1 of 812345...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS